Caredx (CDNA)Divisadero Street Capital Management, LP opened a new position $20M
Divisadero Street Capital Management, LP opened a new position in Caredx, per its Q2 2026 13F.
- 701K
- Shares reported
- 0.45%
- Disclosed portfolio weight
- $20M
- Reported value
- Holdings as of
- Jun 30, 2026
- Filed
- Aug 14, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 6, 2026Federal contract · $1.6M obligatedDepartment of Veterans Affairs awarded CareDx, Inc.: $1.57M obligated to date
- Jun 11, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On June 11, 2026, CareDx, Inc. (the “ Company ”) held its 2026 Annual Meeting of Stockholders (the “ Annual Meeting ”). At the Annual Meeting, the stockholders of the Company approved an amendment (the “ Plan Amendment ”) to the Company’s 2024 Equity Incentive Plan (as previously amended by Amendment No. 1, the “ Plan ”) in accordance with the voting results set forth below under”
- Jun 30, 2026Company filing · Form 8-K · Acquisition or sale, Reg FDCompleted buying or selling a business or assets, and shared information with investors“On June 30, 2026, CareDx, Inc. (the “Company”) completed the previously announced sale of the shares of CareDx AB, a wholly-owned Swedish subsidiary of the Company, and certain assets relating to the Company’s kitted laboratory products business and related software to Eurobio Scientific S.A. (“Eurobio”), pursuant to and subject to the terms and conditions of the Purchase Agreement (the “Purchase Agreement”), by and…”
- Jun 30, 2026Company filing · Form 8-K · Acquisition or saleCompleted buying or selling a business or assets“On July 7, 2026, CareDx, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original 8-K”) with the Securities and Exchange Commission (the “SEC”) reporting the completion of its acquisition of Naveris, Inc., a Delaware corporation (“Naveris”).”
- Jul 13, 2026Federal contract · $1.0M obligatedDepartment of Veterans Affairs awarded CareDx, Inc.: $1.05M obligated to date
- Jul 30, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
What came next
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Caredx
For Caredx, OQRO holds 4 fund holdings reports (13F) and 3 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CDNA page.
How this filing works
Other disclosures at Caredx
- USAspending.gov award recordSep 30, 2026
- USAspending.gov award recordSep 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 13, 2026
- USAspending.gov award recordJul 21, 2026
Everything OQRO holds on this company is on its CDNA page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
